Tumatob, Jimuel D.

HRN: 29-50-43  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2026
CEFTRIAXONE 1G (VIAL)
08/20/2026
08/26/2026
IV
2g
Q12h
Deep Neck Abscess
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: